Bellas - you make some good points. But... The one thing i have...

Bellas - you make some good points. But...

The one thing i have realised working in a Publicly Listed Company is that raising money is never a bad thing. We are not guaranteed of success. If i could raise at at a 5% discount in the middle of a bunch of incomplete trials, then i would do that. Now having a bunch of money in the bank gives me two choices: 1). if my trials are somewhat un-successful i have the opportunity to develop my product by trying different things 2). The cash in the bank gives me the opportunity to possibly acquire new technology (or another product) thereby reducing my reliance on the success of a single product. I am not saying VLA are doing this, but this is some of what comes to my mind.

Getting money from Orbimed has diluted the value for us, but having Orbimed on board validates our product and this will attract some bigger players down the line.